Bank of America’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,186,700
Closed -$53.5M 7423
2025
Q3
$53.5M Buy
1,186,700
+375,100
+46% +$17.5M ﹤0.01% 1693
2025
Q2
$37.6M Buy
811,600
+662,500
+444% +$32.5M ﹤0.01% 1945
2025
Q1
$9.09M Sell
149,100
-242,400
-62% -$14.1M ﹤0.01% 3229
2024
Q4
$22.1M Sell
391,500
-38,200
-9% -$2.13M ﹤0.01% 2213
2024
Q3
$22.2M Sell
429,700
-316,600
-42% -$14.9M ﹤0.01% 2303
2024
Q2
$31M Buy
746,300
+185,400
+33% +$8.3M ﹤0.01% 1839
2024
Q1
$30.4M Buy
560,900
+168,400
+43% +$8.58M ﹤0.01% 1891
2023
Q4
$20.1M Buy
392,500
+82,700
+27% +$4.34M ﹤0.01% 2140
2023
Q3
$18M Sell
309,800
-60,200
-16% -$3.69M ﹤0.01% 2143
2023
Q2
$23.7M Sell
370,000
-228,400
-38% -$15.3M ﹤0.01% 1867
2023
Q1
$41.5M Sell
598,400
-248,400
-29% -$17.5M ﹤0.01% 1503
2022
Q4
$60.9M Sell
846,800
-290,300
-26% -$21.9M 0.01% 1166
2022
Q3
$80.8M Buy
1,137,100
+384,900
+51% +$27.9M 0.01% 951
2022
Q2
$57.9M Sell
752,200
-29,400
-4% -$2.24M 0.01% 1174
2022
Q1
$57.1M Buy
781,600
+415,800
+114% +$27.9M 0.01% 1282
2021
Q4
$22.8M Sell
365,800
-1,735,100
-83% -$102M ﹤0.01% 2096
2021
Q3
$124M Buy
2,100,900
+1,735,300
+475% +$114M 0.01% 845
2021
Q2
$24.4M Sell
365,600
-1,252,500
-77% -$81.7M ﹤0.01% 1962
2021
Q1
$102M Buy
1,618,100
+1,346,700
+496% +$83.8M 0.01% 873
2020
Q4
$16.8M Buy
271,400
+137,800
+103% +$8.47M ﹤0.01% 2042
2020
Q3
$8.05M Sell
133,600
-182,000
-58% -$11M ﹤0.01% 2458
2020
Q2
$18.6M Sell
315,600
-98,400
-24% -$5.89M ﹤0.01% 1669
2020
Q1
$23.1M Sell
414,000
-548,300
-57% -$33.5M ﹤0.01% 1409
2019
Q4
$61.8M Buy
962,300
+81,200
+9% +$4.65M 0.01% 1044
2019
Q3
$44.7M Sell
881,100
-4,400
-0.5% -$207K 0.01% 1207
2019
Q2
$40.2M Sell
885,500
-650,400
-42% -$30.3M 0.01% 1297
2019
Q1
$73.3M Buy
1,535,900
+630,400
+70% +$31.4M 0.01% 882
2018
Q4
$47.1M Buy
905,500
+30,500
+3% +$1.64M 0.01% 1033
2018
Q3
$54.3M Sell
875,000
-92,100
-10% -$5.47M 0.01% 1057
2018
Q2
$53.5M Sell
967,100
-619,000
-39% -$33.4M 0.01% 1044
2018
Q1
$100M Sell
1,586,100
-360,700
-19% -$23.2M 0.02% 710
2017
Q4
$119M Buy
1,946,800
+484,700
+33% +$30.3M 0.02% 653
2017
Q3
$93.2M Sell
1,462,100
-358,300
-20% -$20.9M 0.01% 797
2017
Q2
$101M Buy
1,820,400
+246,100
+16% +$13.4M 0.02% 695
2017
Q1
$85.6M Sell
1,574,300
-75,100
-5% -$4.12M 0.02% 758
2016
Q4
$96.4M Buy
1,649,400
+168,800
+11% +$9.23M 0.02% 684
2016
Q3
$79.8M Buy
1,480,600
+322,600
+28% +$20.7M 0.02% 740
2016
Q2
$85.2M Buy
1,158,000
+351,400
+44% +$24.8M 0.02% 696
2016
Q1
$51.5M Sell
806,600
-540,000
-40% -$34.1M 0.01% 928
2015
Q4
$92.6M Buy
1,346,600
+225,700
+20% +$14.9M 0.02% 693
2015
Q3
$66.4M Buy
1,120,900
+33,900
+3% +$2.15M 0.02% 820
2015
Q2
$72.3M Buy
1,087,000
+101,200
+10% +$6.67M 0.02% 699
2015
Q1
$63.6M Sell
985,800
-167,600
-15% -$10.5M 0.02% 711
2014
Q4
$68.1M Buy
1,153,400
+55,100
+5% +$3.11M 0.02% 709
2014
Q3
$56.2M Buy
1,098,300
+213,800
+24% +$10.7M 0.02% 782
2014
Q2
$42.9M Sell
884,500
-78,300
-8% -$3.86M 0.01% 915
2014
Q1
$50M Sell
962,800
-1,007,900
-51% -$53.6M 0.02% 760
2013
Q4
$105M Buy
1,970,700
+277,300
+16% +$14.1M 0.04% 474
2013
Q3
$78.4M Buy
1,693,400
+549,600
+48% +$24.1M 0.03% 534
2013
Q2
$51.1M Buy
+1,143,800
New +$49.7M 0.02% 690

Other funds holding BMY

Bank of America's BMY Position: Q1 2026 in Review

Bank of America increased its Bristol-Myers Squibb (BMY) stake by 116% in Q1 2026, buying an estimated $1.02B and bringing the position to 32,586,981 shares worth $1.98B. The position accounts for 0.14% of the portfolio, ranked #152.

Bank of America first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.59B in Q2 2022. 2,527 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bank of America held 32,586,981 shares of Bristol-Myers Squibb worth $1.98B as of Q1 2026.
  • Bank of America bought 17,527,686 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.02B.
  • Bristol-Myers Squibb made up 0.14% of Bank of America's portfolio in Q1 2026, its #152 holding.
  • Bank of America first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Bristol-Myers Squibb position peaked at $3.59B in Q2 2022.
  • 2,527 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.